For instance, we could recently demonstrate that DTX3L together with ARTD9 forms a complex with STAT1 and mediates together with ARTD8 and ARTD9 proliferation, chemoresistance and survival of CRPC-like metastatic prostate cancer (mPCa) cells [471]. Here, PARP9 is linked to metastatic prostate carcinoma.